C. Level 3
a. The best initial treatment for the fetus is the provision of optimum resuscitation of the mother and the early assessment of the fetus.
b. All female patients of childbearing age with significant trauma should have a β-HCG performed and be shielded for X-rays whenever possible.
c. Concern about possible effects of high-dose ionizing radiation exposure should not prevent medically indicated maternal diagnostic X-ray procedures from being performed. During pregnancy, other imaging procedures not associated with ionizing radiation should be considered instead of X-rays when possible.
d. Exposure to less than 5 rad has not been associated with an increase in fetal anomalies or pregnancy loss and is herein deemed to be safe at any point during the entirety of gestation.
e. Ultrasonography and MRI are not associated with known adverse fetal effects. However, until more information is available, MRI is not recommended for use in the first trimester.
f. Consultation with a radiologist should be considered for purposes of calculating estimated fetal dose when multiple diagnostic X-rays are performed.
g. Perimortem Cesarean section should be considered in any moribund pregnant woman of ≥ 24 weeks gestation. 
IV. SCIENTIFIC FOUNDATION
Pregnancy is considered a triage criterion for transport to trauma center by the American College of Surgeons Committee on Trauma. Despite this respect given to the care of the injured pregnant patient, the literature is very limited and comprised of mostly class III studies. There are few multicenter studies and many of the other studies are inadequately powered.
The Level 2 guidelines were based predominantly on class II studies. The class II study by Pearlman, et al. indicates monitoring should begin at 20 weeks gestation. 54 The duration of fetal monitoring has been the subject of debate.
Early studies indicating that abruptio placenta, the main obstetric cause of fetal demise, can occur up to 48 hours post-injury led to recommendations for this duration of monitoring. 1, 24 Recommended minimum times of post-trauma monitoring quoted in the literature vary from of 2 to 6 hours in the absence of signs, symptoms or monitoring abnormalities. 5, 16, 19, 32, 73, 75 None of these times, however, have been validated by large, prospective studies. Therefore, we suggest adopting the most conservative estimate of 6 hours while recommending this topic be further investigated by our and other multi-institutional trials groups.
Two Class II studies and one class III study conclude that Kleihauer-Betke testing should be routinely performed in whom blunt uterine trauma is suspected. 47, 54, 57 One study showed an increased incidence of abruptio placenta in those with a positive test. 54 In the latest class III study, the Kleihauer -Betke test was a predictor of preterm labor. 47 As per ACOG recommendations, the main utility of the test is to restrict Rh immune globulin use to those who need it and to detect the few patients for whom that quantity is insufficient. 4 Another option is to administer Rh immune globulin to all unsensitized Rh-negative pregnant patients who have suspected blunt uterine trauma. Then, one would guide additional dosing by the Kleihauer -Betke test results. There is a 72-hour window after fetomaternal hemorrhage within which Rh immune globulin can be administered to provide protection from alloimmunization. The appropriate dose is 300 mcg per 30 ml of fetomaternal hemorrhage.
The first Level III recommendation is based on expert opinion. Advanced Trauma Life Support teaches that "the best initial treatment for the fetus is the provision of optimum resuscitation of the mother and the early assessment of the fetus." The most common cause of fetal demise is maternal demise.
Routine β-HCG testing appears to make sense in our present medico-legal environment. One class II paper recommends routine β-HCG testing due to "incidental pregnancy". 12 Many of our patients arrive without the ability to communicate, with testing being especially important in this group.
As for recommendations c through f, data regarding diagnostic radiation exposure is particularly lacking. Much of the data comes from atomic bomb blasts or large series in cancer registries. Many of these studies have inherent bias making useful conclusions impossible. No study to date has shown any increase in teratogenicity above baseline at fetal exposures below 10 rad or 100 mGy to the fetus. Growth restriction, microcephaly and mental retardation can occur with high dose radiation, well above that used in medical imaging. 13, 50, 51 The fetus is most at risk for central nervous system effects from 8 -15 weeks and the threshold appears to be at least 20 to 40 rad. 50, 51 The American College of Obstetricians and Gynecologists (ACOG) has published recommendations for diagnostic imaging during pregnancy. 5 They state that 5 rad or 50 mGy exposure to the fetus is not associated with any increased risk of fetal loss or birth defects. The reference cited for this dose and statement was a paper concerning counseling of pregnant patients on radiation exposure. There is, however, class III data from our literature search which supports this number. 49 There is no mention regarding leukemia incidence.
Several Class II and III studies have suggested variable increased risk of childhood leukemia above baseline with "low level radiation". 15, 28, 32, 34, 55, 67, 69, 74, 76 There are three class II and III references which show no significant increase in risk. 44, 45, 60 Agreeing with the former studies, the National Radiation Protection estimate an 8% per 100 rad increased risk of childhood cancers. 74 Emergency cesarean section should be differentiated from perimortem cesarean section. Emergency cesarean section may be undertaken for many reasons, including fetal distress, premature rupture of membranes, etc.
Perimortem cesarean section refers to that which is performed at the time of maternal death. The 1996 paper on emergency cesarean section by Morris, et al.
demonstrates the utility of this intervention but only one case in this study was perimortem.
perimortem cesarean section with gestational age at least 24 weeks. 4, 37, 40 The survival and neurological outcome are related to time between maternal death and delivery. Perimortem cesarean section should be ideally started within 4 minutes of maternal arrest , but this recommendation is based on isolated case reports. 4 Review of the literature shows that most survivors were delivered within 5 minutes, but one was delivered greater than 20 minutes after maternal arrest. 37 Emergency cesarean section is potentially an option for fetuses of at least 24 weeks gestation with fetal heart tones and may be indicated for fetal or maternal 
V. FUTURE INVESTIGATIONS
Clearly, given the relatively small number of gravid trauma patients, a multi-center trial is necessary to clarify some of these issues. However, prospective, randomized trials to answer many of these questions would be ©2005 Copyright The Eastern Association for the Surgery of Trauma unethical. Trauma database review with prospective follow-up might provide clarity to many of these issues raised here.
A review of diagnostic studies performed in all pregnant trauma patients in EAST participating institutions over the last 5 or 10 years followed by a prospective phone follow-up at five year intervals to determine presence or absence of childhood cancers could raise enough data to rival that of the studies used in our guideline review. Dose estimates could be calculated from radiographic studies done and correlated with the incidence of childhood cancers.
Questions concerning the Kleihauer-Betke test and monitoring could be answered in part from data that already exists with a chart review of outcomes across EAST participating institutions. A pregnancy trauma score could be modeled on such data with the predictors cited above and prospectively applied in a multi-institutional fashion. We are in a unique position as a premier trauma organization with large membership to be able to comment on all of these issues in a more definitive fashion than ever before. We encourage our colleagues in the Multi-Institutional Trials Committee to take up some of these issues in the near future. 
